Volume 28, Issue s1 pp. S43-S46

A New Dual-Chamber Pacing Mode to Minimize Ventricular Pacing

ARNAUD SAVOURÉ

ARNAUD SAVOURÉ

University Hospitals Rouen, France

Search for more papers by this author
GERD FRÖHLIG

GERD FRÖHLIG

Medizinische Universitatsklinik III, Hamburg, Germany

Search for more papers by this author
DANIEL GALLEY

DANIEL GALLEY

University Hospitals, Albi

Search for more papers by this author
PASCAL DEFAYESYLVAIN REUTERPHILIPPE MABONICOLAS SADOUL

NICOLAS SADOUL

Nancy, France

Search for more papers by this author
AMEL AMBLARD

AMEL AMBLARD

Ela Medical, Le Plessis-Robinson, France

Search for more papers by this author
MARCEL LIMOUSIN

MARCEL LIMOUSIN

Nancy, France

Search for more papers by this author
FREDERIC ANSELME

FREDERIC ANSELME

University Hospitals Rouen, France

Search for more papers by this author
First published: 31 January 2005
Citations: 44
Address for reprints: Frederic Anselme, M.D., University Hospital of Rouen, Service de cardiologie, 1, rue Charles Nicolle, 76000 Rouen, France. e-mail: [email protected]

This study was sponsored by ELA Medical.

Abstract

Despite the low long-term incidence of high-degree atrioventricular (AV) block and the known negative effects of ventricular pacing, programming of the AAI mode in patients with sinus node dysfunction (SND) remains exceptional. A new pacing mode was, therefore, designed to combine the advantages of AAI with the safety of DDD pacing. AAIsafeR behaves like the AAI mode in absence of AV block. First- and second-degree AV blocks are tolerated up to a predetermined, programmable limit, and conversion to DDD takes place in case of high-degree AV block. From DDD, the device may switch back to AAI, provided AV conduction has returned. The safety of AAIsafeR was examined in 43 recipients (70 ± 12-year old, 24 men) of dual chamber pacemakers implanted for SND or paroxysmal AV block. All patients underwent 24-hour ambulatory electrocardiographic recordings before hospital discharge and at 1 month of follow-up with the AAIsafeR mode activated. No AAIsafeR-related adverse event was observed. At 1 month, the device was functioning in AAIsafeR in 28 patients (65%), and the mean rate of ventricular pacing was 0.2%± 0.4%. Appropriate switches to DDD occurred in 15 patients (35%) for frequent, unexpected AV block. AAIsafeR mode was safe and preserved ventricular function during paroxysmal AV block, while maintaining a very low rate of ventricular pacing. The performance of this new pacing mode in the prevention of atrial fibrillation will be examined in a large, controlled study.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.